ArticlePloS one2026
Analysis of catabolic products of L-arginine; L-ornithine and L-citrulline and the residual L-arginine using the HPLC and LC-MS.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
L-arginine, a semi-essential amino acid, is metabolised in the cell to generate nitric oxide (NO) and L-citrulline via the enzyme nitric oxide synthase (NOS) or urea and L-ornithine via arginase activity. L-citrulline and L-ornithine are the products of L-arginine degradation. Mouse liver epithelial (BNL CL2) and mouse embryonic fibroblast (3T3 L1) insulin-sensitive cell lines were used as model systems and cultured with 0, 400 or 800 µM L-Arg. This study focuses on the analysis of the residual concentrations of amino acids (L-Arg, L-Cit and L-Orn) in cell culture medium samples using high performance liquid chromatography that involves precolumn derivatization with o-phthaldialdehyde. In BNL CL2 cells, most of the culture supernatant has increased amount of L-Arg in comparison to the control complete DMEM addition. L-ornithine levels showed an overall increase over time, with higher concentrations observed at 72 h compared with 24 h across all samples. In 3T3 L1 cells, residual L-Arg concentration decreased in most of the cell supernatant in comparison to the control at 72 h. Noticeably, L-Arg at 0 µM and the control complete DMEM had highest amount of L-Orn among all samples. Interestingly, L-Cit was very much high in culture medium of both untreated BNL CL2 (85.96 µM) and 3T3 L1 (37.49 µM) cells at T = 0 compared to the control. Collectively, the results show that excess L-Arg is sensed by the cell which then regulates the residual amount of amino acids concentration. The spectroscopy technique used here is highly sensitive, specific and accurate, can be readily automated and serves as a valuable tool for investigating the modulation of the arginine-nitric oxide pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.